Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSAMG 18 is an inhibitor of inositol-requiring enzyme 1α (IRE1α; IC50 = 0.013 µM).1 It is selective for IRE1α over JNK3 (IC50 = 2.5 µM) and a panel of 100 kinases at 1 µM. AMG 18 inhibits the splicing of X-box binding protein 1 (XBP1) induced by thapsigargin (Item No. 10522) in a reporter assay using HT-1080 cells. It sensitizes 9591PPT and 53631PPT mouse pancreatic ductal adenocarcinoma (PDAC) cells to radiation when used at concentrations of 2.5 or 5 µM.2 AMG 18 (10 µM) reverses increases in fibronectin levels in primary human small airway epithelial cells infected with respiratory syncytial virus (RSV).3 In vivo, AMG 18 (50 mg/kg) decreases blood glucose levels, liver triglyceride and cholesterol levels, and plasma alanine transaminase (ALT) and aspartate aminotransferase (AST) levels in a mouse model of non-alcoholic steatohepatitis (NASH) induced by a methionine- and choline-deficient (MCD) diet.4
WARNING This product is not for human or veterinary use.
1. Unfolded protein response in cancer: IRE1α inhibition by selective kinase ligands does not impair tumor cell viability. ACS Med. Chem. Lett. 6(1), 68-72 (2014).
2. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. Radiother. Oncol. 191:110059, (2024).
3. The IRE1α-
4. KIRA8 attenuates non-